Eris Lifesciences Limited (NSE:ERIS) — Stock Price

Rs1258.90 INR
▼ -1.23% today

Eris Lifesciences Limited (NSE:ERIS) is currently trading at Rs1258.90 INR, down 1.23% today. Over the past 52 weeks, shares have ranged between Rs1258.90 and Rs1701.30. This page tracks Eris Lifesciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Eris Lifesciences Limited (ERIS) market capitalisation.

Eris Lifesciences Limited (ERIS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Eris Lifesciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Eris Lifesciences Limited Income Statement — Revenue, Profit & Earnings by Year

Eris Lifesciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs31.29 Billion Rs28.79 Billion Rs19.91 Billion Rs16.62 Billion Rs13.26 Billion
Cost of Revenue Rs16.32 Billion Rs7.30 Billion Rs3.88 Billion Rs3.57 Billion Rs2.61 Billion
Gross Profit Rs14.98 Billion Rs21.49 Billion Rs16.04 Billion Rs13.05 Billion Rs10.65 Billion
Research & Development — Rs24.40 Million Rs57.20 Million Rs61.00 Million Rs327.38 Million
SG&A — Rs5.08 Billion Rs714.79 Million Rs471.75 Million Rs504.09 Million
Total Operating Expenses Rs6.57 Billion Rs14.46 Billion Rs11.08 Billion Rs8.83 Billion Rs6.40 Billion
Operating Income Rs8.41 Billion Rs7.03 Billion Rs4.95 Billion Rs4.22 Billion Rs4.25 Billion
EBITDA Rs11.11 Billion Rs10.36 Billion Rs6.99 Billion Rs5.48 Billion Rs5.11 Billion
EBIT Rs8.31 Billion Rs7.20 Billion Rs5.16 Billion Rs4.31 Billion Rs4.46 Billion
Interest Expense Rs1.93 Billion Rs2.31 Billion Rs848.01 Million Rs261.68 Million Rs42.19 Million
Income Before Tax Rs6.39 Billion Rs4.89 Billion Rs4.31 Billion Rs4.05 Billion Rs4.42 Billion
Income Tax Expense Rs-89.70 Million Rs1.14 Billion Rs342.20 Million Rs304.83 Million Rs364.09 Million
Net Income Rs6.20 Billion Rs3.52 Billion Rs3.92 Billion Rs3.82 Billion Rs4.06 Billion

Eris Lifesciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Eris Lifesciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs73.66 Billion Rs70.33 Billion Rs70.49 Billion Rs36.67 Billion Rs22.72 Billion
Total Current Assets Rs15.40 Billion Rs12.23 Billion Rs23.02 Billion Rs7.65 Billion Rs6.27 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs216.40 Million Rs50.00 Million Rs12.45 Billion Rs332.21 Million Rs1.63 Billion
Net Receivables Rs7.33 Billion Rs4.59 Billion Rs4.22 Billion Rs2.93 Billion Rs2.09 Billion
Inventory Rs4.37 Billion Rs3.35 Billion Rs1.89 Billion Rs1.31 Billion Rs1.18 Billion
Property, Plant & Equipment — Rs7.29 Billion Rs5.58 Billion Rs3.77 Billion Rs1.92 Billion
Goodwill Rs9.12 Billion Rs9.12 Billion Rs8.61 Billion Rs3.32 Billion Rs934.74 Million
Total Liabilities Rs34.70 Billion Rs37.61 Billion Rs38.27 Billion Rs14.47 Billion Rs3.64 Billion
Total Current Liabilities Rs20.77 Billion Rs13.81 Billion Rs25.32 Billion Rs4.43 Billion Rs2.00 Billion
Long-term Debt Rs9.56 Billion Rs17.38 Billion Rs6.55 Billion Rs6.44 Billion Rs450.00 Million
Net Debt Rs22.91 Billion Rs22.55 Billion Rs26.87 Billion Rs8.21 Billion Rs336.13 Million
Total Stockholder Equity Rs39.03 Billion Rs28.54 Billion Rs25.86 Billion Rs21.96 Billion Rs19.08 Billion
Retained Earnings — Rs27.93 Billion Rs25.41 Billion Rs21.56 Billion Rs18.74 Billion

Eris Lifesciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Eris Lifesciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs3.47 Billion Rs10.65 Billion Rs4.86 Billion Rs2.92 Billion Rs3.78 Billion
Capital Expenditures Rs2.97 Billion Rs1.55 Billion Rs1.29 Billion Rs8.41 Billion Rs1.21 Billion
Free Cash Flow Rs500.70 Million Rs9.10 Billion Rs3.57 Billion Rs-5.50 Billion Rs2.57 Billion
Investing Cash Flow Rs-3.72 Billion Rs-799.70 Million Rs-18.55 Billion Rs-9.82 Billion Rs-3.20 Billion
Financing Cash Flow Rs-1.20 Billion Rs-8.81 Billion Rs13.80 Billion Rs6.88 Billion Rs-446.99 Million
Dividends Paid — Rs-1.00 Billion Rs0.00 Rs999.11 Million Rs816.23 Million
Stock-Based Compensation Rs80.00 Million Rs91.30 Million Rs7.50 Million Rs31.21 Million Rs13.55 Million
Depreciation Rs2.79 Billion Rs3.15 Billion Rs1.83 Billion Rs1.17 Billion Rs647.05 Million
Change in Cash Rs-1.32 Billion Rs1.05 Billion Rs382.23 Million Rs51.52 Million Rs139.55 Million

Eris Lifesciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Eris Lifesciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 29, 2026 10.26 10.77 -4.74%
May 20, 2026 20.57 8.67 +137.25%
Feb 13, 2026 8.26 9.05 -8.73%
Nov 12, 2025 8.81 9.20 -4.24%
Aug 05, 2025 8.64 8.73 -1.03%
May 19, 2025 6.89 7.10 -2.96%
Feb 04, 2025 6.14 6.57 -6.54%
Oct 25, 2024 6.72 7.20 -6.67%